News

Wesbanco Reveals Details of Its New Preferred Stock Offering

Wesbanco Reveals Details of Its New Preferred Stock Offering

Wesbanco's Exciting Offering of Preferred Stock

Wesbanco, Inc. (NASDAQ: WSBC) has recently unveiled its plans for a significant underwritten public offering. This offering involves 9,200,000 depositary shares, each representing a 1/40th interest in a share of 7.375% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B. With a liquidation preference of $1,000 per share, this equates to $25 per depositary share.

Understanding the Dividends

As declared by the board of directors or an authorized committee, dividends will start accruing quarterly, providing investors with attractive returns. The initial rate is set at 7.375% per annum, applicable until October 1, 2030, followed by periodic adjustments correlated to the five-year treasury rate plus a spread.

Redemption Options for Investors

Investors should note that Wesbanco may redeem the Series B Preferred Stock on any dividend payment date post-October 1, 2030. This offer includes a redemption price of $1,000 per share plus any declared dividends. This flexibility in redemptions will be highly valued by potential investors.

Utilization of Proceeds

The proceeds from this offering are earmarked for crucial financial maneuvers that will strengthen Wesbanco’s position. Of the estimated net proceeds, approximately $150 million is allocated to redeem the outstanding 6.75% Series A Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, while another $50 million will go to the redemption of 4.0% Fixed-To-Floating Rate Subordinated Notes due on September 30, 2030.

Future Investments and Financial Goals

The remaining funds will serve various purposes like repayment or refinancing of debts, capital expenditures, and adding to their lending capabilities. Such moves showcase Wesbanco’s strategic focus on enhancing financial health and expanding its operations.

The Role of Leading Financial Firms

To manage this offering effectively, Wesbanco has partnered with established financial institutions. Keefe, Bruyette & Woods, A Stifel Company, RBC Capital Markets, and Raymond James are the joint book-running managers overseeing this public offering.

Market Listing Plans

Wesbanco plans to list the depositary shares on The Nasdaq Global Select Market under the symbol "WSBCPB." This strategic move aims to enhance visibility within the financial market.

About Wesbanco

Wesbanco has built a solid reputation over its 150-plus years of providing financial services. With total assets of $27.6 billion, the institution offers a wide array of banking solutions, including commercial banking, wealth management, and investment services. Their mission focuses on empowering customers for financial success.

Commitment to Community

Wesbanco is dedicated to supporting its communities across its eight-state footprint. By leveraging both large bank capabilities and a local focus, they aspire to make every community a better place for personal and business growth.

Frequently Asked Questions

What is the offering by Wesbanco about?

Wesbanco announced an offering of 9,200,000 depositary shares linked to their newly issued Series B Preferred Stock with competitive dividend rates.

When can shareholders expect dividends?

The dividends will primarily begin on January 1, 2026, and will be distributed quarterly after that date.

What will the proceeds from the offering be used for?

Proceeds are expected to be used for redeeming existing preferred stock, repaying debt, and enhancing general corporate purposes.

Are there any parties managing the offering?

Yes, Keefe, Bruyette & Woods, RBC Capital Markets, and Raymond James are managing this offering effectively.

How will the Series B Preferred Stock impact Wesbanco?

This offering is expected to provide Wesbanco with greater financial flexibility and enhance its growth prospects moving forward.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading

Top 5 Most Recently Viewed Articles

Abionic's Innovative IVD CAPSULE PSP Receives FDA Clearance

Updated Category News Views 96

Abionic achieved FDA 510(k) clearance for its IVD CAPSULE PSP back in 2024, marking a pivotal point in medical diagnostics. Desks were buzzing as traders recognized the potential of this test to accelerate sepsis detection—an urgent health crisis impacting around 50 million patients globally each year. Sepsis: A Global Health Emergency Sepsis isn't just another medical...

Continue Reading
Revolutionizing Patient Care with Avextra's Breakthrough Capsules

Updated Category News Views 135

Avextra's Innovative Approach to Patient-Centric Therapy With evidence-based clinical development and new pharmaceutical formulations, Avextra aims to enhance patient experience and adherence. In the ever-evolving realm of medical therapies, the question arises: How can treatments involving Cannabis-based medicines (CbM) be both effective and user-friendly? Traditionally,...

Continue Reading
LIBERTY Dental Plan Provides Significant Support for Hurricane Aid

Updated Category News Views 33

LIBERTY Dental Plan's Generosity Shines in Crisis LIBERTY Dental Plan of Florida, Inc. (LIBERTY), a prominent dental benefits administrator, is stepping up to aid communities affected by devastating hurricanes. With a timely donation of $10,000, LIBERTY is supporting hurricane relief efforts aimed at restoring normalcy in impacted areas. A Helping Hand for Florida...

Continue Reading
Discover the Growth of $1000 in Lloyds Banking Group

Updated Category News Views 218

The Transformation of a $1000 Investment in Lloyds Banking Group Lloyds Banking Group (NYSE: LYG) has shown impressive growth over the last five years, outpacing the market with an annualized return of 20.92%. With a current market capitalization of $82.67 billion, it’s a notable player in the financial sector. How Much Would Your Investment Be Worth? For an investor...

Continue Reading
Understanding KKR's Growth: A Decade of Investment Success

Updated Category News Views 652

Investing in KKR: A 10-Year Journey Investing wisely is all about understanding the market and making informed choices. Over the last decade, KKR has emerged as a prominent player, significantly outperforming the market with an annualized return of 19.02%. With a current market capitalization of approximately $119.00 billion, KKR’s growth story is nothing short of...

Continue Reading